Breast Cancer Research and Treatment

Springer Science+Business Media

Journal websitePeer review: Peer review
Evaluation status available after sign-in

About the journal

Breast Cancer Research and Treatment is a journal published by Springer Science+Business Media in Netherlands. It is listed in MEDLINE according to the sources read. Declared publication charge: 3,790 EUR. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.

Basic facts

Publisher
Springer Science+Business Media
ISSN
0167-6806 · 1573-7217
Country
Netherlands
Access
Not open access / not declared
Declared publication charge
3,790 EUR
Declared peer-review model
peer_review

Index listings

  • MEDLINE · 1981-01-01
Indexing
MEDLINE
APC
3,790 EUR
Declared review time (DOAJ)
—
Actual review time (measured)
106 days received→accepted — computed from PubMed (n=97)
Activity (OpenAlex)
Active — latest works 2026
PublishLens list status
Shown after sign-in
Counts for promotion at your university?
Choose your university and rank below ↓

Methodology signals (dated facts from their sources)

Details of the evaluation under the published methodology are shown to signed-in users (free).

Create a free account to view the evaluation

Journal profile

Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.

Works in OpenAlex

12432

Last recorded publication year

2026

Reported by OpenAlex in 1 of 3 sources (CC0 flags, not verified indexing)DOAJSciELOOpenAlex Core

h-index

221

i10-index

8792

From OpenAlex open data (CC0).

Editorial & policy5
Observed digital preservation (Keepers registry)— snapshot 2026-10-05
CLOCKSSPortico
Norwegian register (HK-dir)— 2026
Level 1 — approved scholarly channel
Open references deposited at Crossref
96%
ORCID iDs in current deposits
45%
Enrolled in Crossref Similarity Check
✓
Deposits licence metadata at Crossref
✓
Identity & continuity2
Source type
journal
NLM unique ID (PubMed)
8111104
Classification(no data)

No data available to the platform for this group

No platform data for: Classification — absence is not a judgment about the journal.

Subject areas

  • Breast Cancer Treatment Studies
  • Breast Cancer Treatment Studies
  • Estrogen and related hormone effects
  • Estrogen and related hormone effects
  • HER2/EGFR in Cancer Research
  • HER2/EGFR in Cancer Research
  • Breast Lesions and Carcinomas
  • Breast Lesions and Carcinomas
Show all subjects (50)
  • BRCA gene mutations in cancer
  • BRCA gene mutations in cancer
  • Cancer Risks and Factors
  • Cancer Risks and Factors
  • Global Cancer Incidence and Screening
  • Global Cancer Incidence and Screening
  • Cancer Treatment and Pharmacology
  • Cancer Treatment and Pharmacology
  • Advanced Breast Cancer Therapies
  • Advanced Breast Cancer Therapies
  • Cancer Cells and Metastasis
  • Cancer Cells and Metastasis
  • Breast Implant and Reconstruction
  • Breast Implant and Reconstruction
  • Cancer survivorship and care
  • Cancer survivorship and care
  • Cancer Genomics and Diagnostics
  • Cancer Genomics and Diagnostics
  • Cancer-related Molecular Pathways
  • Cancer-related Molecular Pathways
  • DNA Repair Mechanisms
  • DNA Repair Mechanisms
  • Monoclonal and Polyclonal Antibodies Research
  • Monoclonal and Polyclonal Antibodies Research
  • Metabolism, Diabetes, and Cancer
  • Metabolism, Diabetes, and Cancer
  • Digital Radiography and Breast Imaging
  • Digital Radiography and Breast Imaging
  • Male Breast Health Studies
  • Male Breast Health Studies
  • Genetic factors in colorectal cancer
  • Genetic factors in colorectal cancer
  • Cancer Immunotherapy and Biomarkers
  • Cancer Immunotherapy and Biomarkers
  • Medical Imaging Techniques and Applications
  • Medical Imaging Techniques and Applications
  • Cancer-related cognitive impairment studies
  • Cancer-related cognitive impairment studies
  • Lymphatic System and Diseases
  • Lymphatic System and Diseases
  • Epigenetics and DNA Methylation
  • Epigenetics and DNA Methylation

Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.

Loading community confirmations…
How do we evaluate?Publisher of this journal? Appeal a derived assessment or request a factual correction

The journal's record in other sources:Web of Science MJLDOAJ

Everything shown here is produced automatically from named sources (DOAJ, OpenAlex, Crossref, PubMed, the Norwegian register) as of its capture date, with no human editing. Facts appear as recorded at the source; derived scores (PCI, PTD, PublishLens score) follow a published methodology. Not a judgement on the journal, not an official accreditation, not advice.

Wrong items are corrected automatically by re-reading the source (24 h for daily sources, 7 days for weekly ones) with a dated change log, and each item links to its source record. PublishLens-derived assessments are contested through the appeals mechanism (15 working days). Appeals · Indicator guide

Norwegian register data: Kanalregisteret (HK-dir, Norway) — CC BY 4.0 / NLOD — adapted: level extracted per year · OASPA member list — CC BY

Last automated source read: